As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Potenziare l’Arpa Sicilia attraverso nuove risorse umane ed economiche, con un finanziamento di due milioni di euro, nelle aree maggiormente critiche. “Per i prossimi tre anni l’Agenzia ...

HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This ...

Here’s how the county has allocated its ARPA dollars. Lancaster city is a bit of an anomaly when it comes to ARPA funding, in two senses. First, it received nearly 10 times more in federal ...

Editor's note: This story was edited at 12:35 p.m. on Monday, Jan. 27, to update the total general government, streets infrastructure and recreation expenses after LNP received adjusted numbers ...

Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...

The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus, designated as mRNA-1403. This vaccine is designed to protect against multiple norovirus ...

Moderna secures a multi-year agreement to supply its COVID-19 vaccine to 17 European countries, including Norway and North Macedonia. Vaccine formats include prefilled syringes, reducing ...

Dorothy Fink halts reports from health agencies like the CDC, FDA and National Institutes of Health on Tuesday, The H5 bird flu is widespread in wild birds and is causing outbreaks in poultry and ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the ...

Days before President Donald Trump took office a second time, the Department of Health and Human Services granted Moderna $590 million for the development of mRNA vaccines for bird flu and other ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...